How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview

Emerging anti-vascular endothelial growth factor (anti-VEGF) therapies for neovascular age-related macular degeneration (nAMD) have revolutionised medical retina practice and the management and eventual outcome of nAMD. Recent research has focused on evaluating and comparing the efficacy of the two...

Descripción completa

Detalles Bibliográficos
Autores principales: Empeslidis, Theodoros, Storey, Matthew, Giannopoulos, Theodoros, Konidaris, Vassileios, Tranos, Paris G., Panagiotou, Evangelia S., Voudouragkaki, Irini C., Konstas, Anastasios G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824395/
https://www.ncbi.nlm.nih.gov/pubmed/31102206
http://dx.doi.org/10.1007/s12325-019-00971-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824395/
https://www.ncbi.nlm.nih.gov/pubmed/31102206
http://dx.doi.org/10.1007/s12325-019-00971-0

Ejemplares similares